Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Getting ready for the European Health Data Space (EHDS): IDERHA's plan to align with the latest EHDS requirements for the secondary use of health data.
Hussein R, Balaur I, Burmann A, Ćwiek-Kupczyńska H, Gadiya Y, Ghosh S, Jayathissa P, Katsch F, Kremer A, Lähteenmäki J, Meng Z, Morasek K, C Rancourt R, Satagopam V, Sauermann S, Scheider S, Stamm T, Muehlendyck C, Gribbon P. Hussein R, et al. Among authors: lahteenmaki j. Open Res Eur. 2024 Jul 30;4:160. doi: 10.12688/openreseurope.18179.1. eCollection 2024. Open Res Eur. 2024. PMID: 39185338 Free PMC article.
Interoperability of personal health records.
Lahteenmaki J, Leppanen J, Kaijanranta H. Lahteenmaki J, et al. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:1726-9. doi: 10.1109/IEMBS.2009.5333559. Annu Int Conf IEEE Eng Med Biol Soc. 2009. PMID: 19964259
Mobile health and wellness application framework.
Laakko T, Leppänen J, Lähteenmäki J, Nummiaho A. Laakko T, et al. Among authors: lahteenmaki j. Methods Inf Med. 2008;47(3):217-22. doi: 10.3414/me9113. Methods Inf Med. 2008. PMID: 18473087 Review.
Active assistance technology reduces glycosylated hemoglobin and weight in individuals with type 2 diabetes: results of a theory-based randomized trial.
Orsama AL, Lähteenmäki J, Harno K, Kulju M, Wintergerst E, Schachner H, Stenger P, Leppänen J, Kaijanranta H, Salaspuro V, Fisher WA. Orsama AL, et al. Among authors: lahteenmaki j. Diabetes Technol Ther. 2013 Aug;15(8):662-9. doi: 10.1089/dia.2013.0056. Epub 2013 Jul 11. Diabetes Technol Ther. 2013. PMID: 23844570 Clinical Trial.
CYP3A4*22 may increase bleeding risk in ticagrelor users.
Liedes H, Pajula J, Vuorinen AL, De Pretis F, van Gils M, Harno K, Lehto M, Niemi M, Lähteenmäki J. Liedes H, et al. Among authors: lahteenmaki j. Basic Clin Pharmacol Toxicol. 2023 Aug;133(2):202-207. doi: 10.1111/bcpt.13884. Epub 2023 May 31. Basic Clin Pharmacol Toxicol. 2023. PMID: 37162098 Free article. No abstract available.
26 results